Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?

UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention, Catherine Hankins, John Hargrove, Brian Williams, Laith Abu-Raddad, Bertran Auvert, Lori Bollinger, Rob Dorrington, Azra Ghani, Ron Gray, Tim Hallett, James G Kahn, Nicolai Lohse, Nico Nagelkerke, Travis Porco, George Schmid, John Stover, Helen Weiss, Alex Welte, Peter White, Richard White, UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention, Catherine Hankins, John Hargrove, Brian Williams, Laith Abu-Raddad, Bertran Auvert, Lori Bollinger, Rob Dorrington, Azra Ghani, Ron Gray, Tim Hallett, James G Kahn, Nicolai Lohse, Nico Nagelkerke, Travis Porco, George Schmid, John Stover, Helen Weiss, Alex Welte, Peter White, Richard White

Abstract

Experts from UNAIDS, WHO, and the South African Centre for Epidemiological Modelling report their review of mathematical models estimating the impact of male circumcision on HIV incidence in high HIV prevalence settings.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Reductions in HIV incidence by…
Figure 1. Reductions in HIV incidence by coverage level.
This figure shows model estimates for the reduction in HIV incidence 10 y after the programme begins, among circumcised men, women, uncircumcised men, and the population overall, at varying levels of circumcision uptake (from a baseline of 0%). The model is a deterministic compartmental simulation of the heterosexual spread of HIV in a sex- and sexual-activity stratified population, parameterised for Southern and Eastern African populations. The model assumes that there is a 60% reduction in female-to-male transmission for circumcised men, that there is no direct reduction in male-to-female transmission from circumcised men, and that 5%, 20%, 35%, 50%, 70%, and 90% of men are circumcised within 10 y of the intervention being scaled-up. Note: Since the fraction of men circumcised increases over time, the weighted-average of reductions in incidence in these demographic groups at year 10 is not expected to equal the reduction in incidence in the whole population over the first 10 y of the intervention.

References

    1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298. doi: .
    1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–656.
    1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–666.
    1. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000;14:2361–2370.
    1. Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, et al. Male circumcision for HIV prevention: from evidence to action? AIDS. 2008;22:567–574.
    1. WHO/UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications. 2007. Available: . Accessed 13 August 2009.
    1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. The protective effect of male circumcision is sustained for at least 42 months: results from the Kisumu, Kenya Trial [Presentation THAC0501]. 2008. In: Proceedings of the XVII International AIDS Conference; 3–8 August 2008. Mexico City, Mexico. Available: . Accessed 13 August 08.
    1. Gostin LO, Hankins CA. Male circumcision as an HIV prevention strategy in sub-Saharan Africa: sociolegal barriers. JAMA. 2008;300:2539–2541.
    1. UNAIDS. Safe, voluntary, informed male circumcision and comprehensive HIV prevention programming. Guidance for decision-makers on human rights, ethical and legal considerations. 2007. Available: . Accessed 13 August 2009.
    1. UNAIDS. Legal and Regulatory Self-Assessment Tool for Male Circumcision in Sub-Saharan Africa. 2008. Available: . Accessed 13 August 2009.
    1. Fieno JV. Costing adult male circumcision in high HIV prevalence, low circumcision rate countries. AIDS Care. 2008;20:515–520.
    1. Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis. 2007;7:16.
    1. Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS. 2007;21:845–850.
    1. Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med. 2006;3:e262. doi: .
    1. Hallett TB, Singh K, Smith JA, White RG, Abu-Raddad LJ, et al. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS ONE. 2008;3:e2212. doi: .
    1. Alsallaq R, Abu-Raddad L. Male circumcision is a leading factor behind the differential HIV prevalence in Sub-Saharan Africa [Poster MOPE0254]. 2008. In: Proceedings of the XVII International AIDS Conference. Mexico City, Mexico. Available: . Accessed 13 August 2009.
    1. White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R, et al. Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS. 2008;22:1841–1850.
    1. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006;3:e517. doi: .
    1. Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, et al. Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS ONE. 2008;3:e2679. doi: .
    1. Krieger JN, Bailey RC, Opeya J, Ayieko B, Opiyo F, et al. Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya. BJU Int. 2005;96:1109–1113.
    1. Martin G, Bollinger L, Pandit-Rajani T, Tshehlo R, Stover J. Costing male circumcision in Lesotho and implications for the cost-effectiveness of circumcision as an HIV intervention. Washington, D.C.: USAID Health Policy Initiative; 2007. Available: . Accessed 13 August 2009.
    1. Martin G, Bollinger L, Pandit-Rajani T, Nakambula R, Stover J. Costing male circumcision in swaziland and implications for the cost-effectiveness of circumcision as an HIV intervention. Washington, D.C.: USAID Health Policy Initiative; 2007. Available: . Accessed 13 August 2009.
    1. Martin G, Bollinger L, Pandit-Rajani T, Forsythe S, Stover J. Costing male circumcision in Zambia and implications for the cost-effectiveness of circumcision as an HIV intervention. Washington, D.C.: USAID Health Policy Initiative; 2007. Available: . Accessed 13 August 2009.
    1. Londish GJ, Murray JM. Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol. 2008;37:1246–1253.
    1. Podder CN, Sharomi O, Gumel AB, Moses S. To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control. Bull Math Biol. 2007;69:2447–2466.
    1. Millett GA, Flores SA, Marks G, Reed JB, Herbst JH. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA. 2008;300:1674–1684.
    1. Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. 2006;332:605–607.
    1. Hankins C. Male circumcision: implications for women as sexual partners and parents. Reprod Health Matters. 2007;15:62–67.
    1. Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2007;11:341–355.
    1. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921–929.
    1. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet. 2009;374:229–237.
    1. Tobian A, Serwadda D, Quinn T, Kigozi G, Reynolds SJ, et al. Trial of male circumcision: prevention of HSV-2 in men and vaginal infections in female partners, Rakai, Uganda [Abstract 28LB]. 2008. In: Proceedings of the 15th Conference on Retrovirus and Opportunistic Infections; 3–6 February 2008; Boston, Massachusetts, United States. Available: . Accessed 13/08/09.
    1. Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect. 2006;82:101–109; discussion 110.
    1. Wawer M, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, et al. Trial of male circumcision in HIV+ men, Rakai, Uganda: effects in HIV+ men and in women partners [Abstract 33LB]. In: Proceedings of the 15th Conference on Retrovirus and Opportunistic Infections; 3-6 February 2008; Boston, Massachusetts, United States. Available: . Accessed 13 August 09.
    1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol. 2009;200:42 e41–47.
    1. Zenilman JM, Fresia A, Berger B, McCormack WM. Bacterial vaginosis is not associated with circumcision status of the current male partner. Sex Transm Infect. 1999;75:347–348.
    1. Boily MC, Desai K, Masse B, Gumel A. Incremental role of male circumcision on a generalised HIV epidemic through its protective effect against other sexually transmitted infections: from efficacy to effectiveness to population-level impact. Sex Transm Infect. 2008;84(Suppl 2):ii28–34.
    1. Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4:165–172.
    1. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224–236.
    1. Mattson CL, Campbell RT, Bailey RC, Agot K, Ndinya-Achola JO, et al. Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS ONE. 2008;3:e2443. doi: .
    1. Agot KE, Kiarie JN, Nguyen HQ, Odhiambo JO, Onyango TM, et al. Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr. 2007;44:66–70.
    1. Zaba B. Diverse age patterns of HIV incidence rates in Africa [Presentation TUAC0201]. 2008. In: Proceedings of the XVII International AIDS Conference; 3–8 August 2008. Mexico City, Mexico. Available: . Accessed 13/08/2009.
    1. Manicaland HIV/STD Prevention Project. Mathematical modelling tools in the response to the HIV epidemic in Zimbabwe. Harare, Zimbabwe: Manicaland HIV/STD Prevention Project. London: Imperial College London & Biomedical Research and Training Institute; 2008.
    1. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.
    1. Martin G, Bollinger L, Pandit-Rajani T, Tshehlo R, Nkambula R, et al. Costing male circumcision in Lesotho, Swaziland, and Zambia: implications for the cost-effectiveness of circumcision as an HIV intervention. Washington DC: USAID Health Policy Initiative; 2007. Available: . Accessed 13 August 2009.
    1. UNAIDS. Financial resources required to achieve universal access to prevention, treatment, care and support. 2007. Available: . Accessed 13 August 2009.
    1. Futures Institute. Decision-makers' programme planning tool for male circumcision scale-up. 2008. Available: . Accessed 13 August 2009.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren